Anebulo Pharmaceuticals, Inc. (ANEB) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts ANEB Hot Sheet
Join SI Premium – FREE
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q2 EPS of ($0.15), $0.04 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
- Berenberg Upgrades Bayerische Motoren Werke AG (BMW:GR) (BMWYY) to Buy
- RBC Capital Upgrades CSL Ltd. (CSL:AU) (CMXHF) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
